Dr. Ivan Griffin
Co-Founder
Appointed to role
April 2022, having previously been COO and held other roles at BenevolentAI Ltd since February 2014.
Skills and experience
Ivan has nearly 20 years of experience working with early-stage life science and technology companies. He was a Co-Founder of Benevolent having previously worked as a venture capitalist at IP Group Plc from 2005 to 2009 and at Nesta Investments from 2009 to 2014.
In 2013, Ivan helped launch Genomics England Ltd, a nationwide DNA sequencing programme linking genomic data with NHS records of patients with rare disease and cancer.
Ivan holds a D.Phil. in Cognitive Neuroscience from the University of Oxford where he also completed a year’s postdoctoral research.